185 related articles for article (PubMed ID: 34244325)
1. Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer.
Stremke ER; Wiese GN; Moe SM; Wastney ME; Moorthi RN; Hill Gallant KM
J Am Soc Nephrol; 2021 Aug; 32(8):2057-2069. PubMed ID: 34244325
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Phosphorus Absorption in Chronic Kidney Disease.
Stremke ER; Hill Gallant KM
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30249044
[TBL] [Abstract][Full Text] [Related]
3. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
5. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
6. Acid Load and Phosphorus Homeostasis in CKD.
Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
[TBL] [Abstract][Full Text] [Related]
7. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
8. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
[TBL] [Abstract][Full Text] [Related]
9. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
Kim CS; Bae EH; Ma SK; Han SH; Lee KB; Lee J; Oh KH; Chae DW; Kim SW;
J Korean Med Sci; 2017 Feb; 32(2):240-248. PubMed ID: 28049234
[TBL] [Abstract][Full Text] [Related]
10. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
[TBL] [Abstract][Full Text] [Related]
11. Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease.
Goto S; Nakai K; Kono K; Yonekura Y; Ito J; Fujii H; Nishi S
Clin Exp Nephrol; 2014 Dec; 18(6):925-31. PubMed ID: 24578219
[TBL] [Abstract][Full Text] [Related]
12. Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.
Viaene L; Meijers BK; Vanrenterghem Y; Evenepoel P
Am J Nephrol; 2012; 35(5):434-41. PubMed ID: 22538635
[TBL] [Abstract][Full Text] [Related]
13. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
[TBL] [Abstract][Full Text] [Related]
15. Disordered FGF23 and mineral metabolism in children with CKD.
Portale AA; Wolf M; Jüppner H; Messinger S; Kumar J; Wesseling-Perry K; Schwartz GJ; Furth SL; Warady BA; Salusky IB
Clin J Am Soc Nephrol; 2014 Feb; 9(2):344-53. PubMed ID: 24311704
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.
Chang AR; Miller ER; Anderson CA; Juraschek SP; Moser M; White K; Henry B; Krekel C; Oh S; Charleston J; Appel LJ
Am J Kidney Dis; 2017 Feb; 69(2):200-209. PubMed ID: 27865566
[TBL] [Abstract][Full Text] [Related]
17. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
Liabeuf S; Ryckelynck JP; El Esper N; Ureña P; Combe C; Dussol B; Fouque D; Vanhille P; Frimat L; Thervet E; Mentaverri R; Prié D; Choukroun G;
Clin J Am Soc Nephrol; 2017 Dec; 12(12):1930-1940. PubMed ID: 29074818
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
Phelps KR; Mason DL
Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
[TBL] [Abstract][Full Text] [Related]
19. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
[TBL] [Abstract][Full Text] [Related]
20. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.
Moe SM; Zidehsarai MP; Chambers MA; Jackman LA; Radcliffe JS; Trevino LL; Donahue SE; Asplin JR
Clin J Am Soc Nephrol; 2011 Feb; 6(2):257-64. PubMed ID: 21183586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
